|
CBWD6 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.375600E-01 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
5.196800E-01 |
| Normal-vs-Stage2 |
2.315200E-01 |
| Normal-vs-Stage3 |
5.270100E-02 |
| Normal-vs-Stage4 |
1.226360E-02 |
| Stage1-vs-Stage2 |
4.312600E-01 |
| Stage1-vs-Stage3 |
8.015800E-02 |
| Stage1-vs-Stage4 |
1.852270E-02 |
| Stage2-vs-Stage3 |
7.983600E-01 |
| Stage2-vs-Stage4 |
3.849000E-01 |
| Stage3-vs-Stage4 |
4.162600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
5.373800E-01 |
| Normal-vs-AfricanAmerican |
1.758280E-02 |
| Normal-vs-Asian |
2.297000E-01 |
| Caucasian-vs-AfricanAmerican |
1.149830E-02 |
| Caucasian-vs-Asian |
3.971200E-01 |
| AfricanAmerican-vs-Asian |
9.686000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.207400E-01 |
| Normal-vs-Female |
3.665600E-01 |
| Male-vs-Female |
7.709800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
6.104600E-01 |
| Normal-vs-Extreme_Weight |
2.624600E-01 |
| Normal-vs-Obese |
1.899670E-02 |
| Normal-vs-Extreme_Obese |
4.003800E-01 |
| Normal_Weight-vs-Extreme_Weight |
6.150000E-01 |
| Normal_Weight-vs-Obese |
8.347900E-02 |
| Normal_Weight-vs-Extreme_Obese |
3.112600E-01 |
| Extreme_Weight-vs-Obese |
6.768100E-02 |
| Extreme_Weight-vs-Extreme_Obese |
2.495200E-01 |
| Obese-vs-Extreme_Obese |
1.448780E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.387390E-01 |
| Normal-vs-Age(41-60Yrs) |
2.304600E-01 |
| Normal-vs-Age(61-80Yrs) |
4.821800E-01 |
| Normal-vs-Age(81-100Yrs) |
7.154100E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.814000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.035000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
6.064600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.495400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.028800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.642620E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
2.194400E-01 |
| Normal-VS-Type2 PRCC |
7.074600E-01 |
| Normal-VS-KIRP CIMP |
5.561800E-02 |
| Normal-VS-Unclassified PRCC |
6.032400E-02 |
| Type1 PRCC-VS-Type2 PRCC |
4.362600E-01 |
| Type1 PRCC-VS-KIRP CIMP |
1.836180E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
2.828200E-01 |
| Type2 PRCC-VS-KIRP CIMP |
2.410500E-02 |
| Type2 PRCC-VS-Unclassified PRCC |
1.200410E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
4.205600E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
9.755600E-02 |
| Normal-vs-N1 |
1.252260E-02 |
| Normal-vs-N2 |
1.318390E-01 |
| N0-vs-N1 |
2.661000E-01 |
| N0-vs-N2 |
3.411800E-01 |
| N1-vs-N2 |
4.141400E-01 |
|
|
